| Dr Jerome Ekundayo Calloway, MD | |
|
255 E 98th St, Brooklyn, NY 11212-8817 | |
| (718) 240-2644 | |
| Not Available |
| Full Name | Dr Jerome Ekundayo Calloway |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 255 E 98th St, Brooklyn, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003211475 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 277533 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jerome Ekundayo Calloway, MD 255 E 98th St, Brooklyn, NY 11212-8817 Ph: () - | Dr Jerome Ekundayo Calloway, MD 255 E 98th St, Brooklyn, NY 11212-8817 Ph: (718) 240-2644 |
News Archive
A team of Swedish and American scientists has shown for the first time that carbon nanotubes can be broken down by an enzyme - myeloperoxidase - found in white blood cells. Their discoveries are presented in Nature Nanotechnology and contradict what was previously believed, that carbon nanotubes are not broken down in the body or in nature.
Some mouse sperm can discriminate between its brethren and competing sperm from other males, clustering with its closest relatives to swim faster in the race to the egg. But this sort of cooperation appears to be present only in certain promiscuous species, where it affords an individual's sperm a competitive advantage over that of other males.
The Commonwealth Fund is out Wednesday with a report that shows the unemployed are skipping out on important medical services and recommends Congress extend COBRA subsidies through 2014. The study found that 72 percent of people who have lost their employer health insurance didn't fill prescriptions, get recommended tests or see a doctor because of the high cost barrier.
Inoviem Scientific, a Contract Research Biotech (CRB) company today announces that it has received additional funding of €545,000 ($611,000) from French public investment bank bpifrance. The company leverages two proprietary technologies to offer pharmaceutical players increased speed and enhanced safety at all stages of drug development; from drug discovery (the identification of secondary targets and detection of potential adverse effects, etc.) through to clinical trials (with patient stratification and identification of biomarkers, etc.).
› Verified 7 days ago
Yves H Jean, MD General Practice Medicare: Medicare Enrolled Practice Location: 451 63rd St # 2f, Brooklyn, NY 11220 Phone: 347-335-3154 | |
Munther Alshalabi, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 297 Marcus Garvey Blvd # 11221, Brooklyn, NY 11221 Phone: 917-615-2343 | |
Ghulam Qutab, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 48 Cedar St, Brooklyn, NY 11221 Phone: 718-455-6200 | |
Zuleika Parra, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 374 Stockholm St, Brooklyn, NY 11237 Phone: 718-963-7272 | |
Luis Mercado, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 374 Stockholm St, Brooklyn, NY 11237 Phone: 718-963-7272 | |
Anita C Siu, General Practice Medicare: Not Enrolled in Medicare Practice Location: 3024 Avenue I, Brooklyn, NY 11210 Phone: 718-951-2519 Fax: 718-258-0654 |